Repligen | RGEN - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Agilent USD 1.04B 52M 2026-06
Align Technology USD 757.43M 20.84M 2026-06
Bio Techne USD 222.15M 13.86M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Bruker USD 416M 36.2M 2026-06
Charles River Laboratories USD 348.78M 69.47M 2026-06
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 493M 66M 2026-06
General Electric Aerospace USD 4.46B 220M 2026-06
Henry Schein USD 1.03B 39M 2026-06
Illumina USD 770M 49M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pfizer USD -248M 11.29B 2026-06
Repligen USD 110.04M 1.75M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Standard Biotools USD 11.31M 74K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 490M 52M 2026-06
West Pharmaceutical Services USD 296.4M 7.5M 2026-03